Home Health Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review

Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review

by News Desk
0 comment
    • Zintzalas E.
    • Vulgarelis M.
    • Musopoulos HM

    The risk of developing lymphoma in autoimmune diseases: a meta-analysis.

    Arch Intern Med. 2005; 165: 2337-2344

  • Autoimmunity and lymphomagenesis.

    Int J Cancer. 2009; 124: 1497-1502

    • Rostami S.
    • Hoff M.
    • Brown MA
    • and others.

    Prediction of ankylosing spondylitis in HUNT studies with a genetic risk score combining 110 single-nucleotide polymorphisms of significance across the genome.

    J Rheumatism. 2020; 47: 204-210

    • International Genetics of the Ankylosing Spondylitis Consortium

    Identification of multiple risk variants for ankylosing spondylitis by high-density genotyping of immune-related loci.

    Nat June. 2013; 45: 730-738

    • Chowdrefson B.
    • Galeson AJ
    • Bjornsson S.
    • Bjarnason I.

    Common genetic background of inflammatory bowel disease and ankylosing spondylitis: A genealogical study in Iceland.

    Arthritic rheumatism. 2007; 56: 2633-2639

    • Mierants H.
    • Vais EM
    • Cuvelier C.
    • De Vos M.
    • Botelberge L.

    HLA-B27-associated arthritis and intestinal inflammation, Part 2: Ilecolonoscopy and intestinal histology in patients with HLA-B27-associated arthritis.

    J Rheumatism. 1985; 12: 294-298

    • Beaujerie L.
    • Bulls N.
    • Bouvier AM
    • and others.
    • CESAME Study Group

    Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

    lancet. 2009; 374: 1617-1625

    • Afif W.
    • Sandborn WJ
    • Forbion WA
    • and others.

    Lymphoma risk factors in patients with inflammatory bowel disease: a case-control study.

    Inflammatory bowel disease. 2013; 19: 1384-1389

    • Pedersen N.
    • Durikova D.
    • Elkyer M.
    • Gumborg M.
    • Munkholm P.
    • Jess T.

    Extraintestinal cancer risk in inflammatory bowel disease: a meta-analysis of population-based cohort studies.

    J digestive system. 2010; 105: 1480-1487

    • Fertelius N.
    • Ekbom A.
    • Bronqvist P.

    Cancer incidence in patients with ankylosing spondylitis in Sweden from 1965 to 1995: a population-based cohort study.

    An Reum Dis. 2003; 62: 1185-1188

    • Becker N.
    • Deeg E.
    • Rudiger T.
    • Nieters A.

    Lymphoma history and risk: results of a population-based case-control study in Germany.

    Eur J Cancer. 2005; 41: 133-142

    • Askling J.
    • Clarescog L.
    • Bronqvist P.
    • Ford M.
    • Fertelius N.

    Risk of malignant lymphoma in ankylosing spondylitis: a Swedish national case-control study.

    An Reum Dis. 2006; 65: 1184-1187

    • Rundgren O.
    • Engels EA
    • Pfeiffer RM
    • and others.

    Autoimmunity and susceptibility to Hodgkin’s lymphoma: a population-based case-control study in Scandinavia.

    J National Cancer Institute. 2006; 98: 1321-1330

    • Rundgren O.
    • Lynette MS
    • McMaster ML
    • Gridley G.
    • Haeminki K.
    • goldin LR

    Familial features of autoimmune and hematological disorders in 8,406 patients with multiple myeloma: a population-based case-control study.

    Int J Cancer. 2006; 118: 3095-3098

    • Rundgren O.
    • Engels EA
    • Caporazo NE
    • and others.

    Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

    blood. 2006; 108: 292-296

    • Melemkiel L.
    • Pfeiffer RM
    • Engels EA
    • and others.

    Autoimmune disease in individuals and relatives, and susceptibility to non-Hodgkin’s lymphoma.

    Arthritic rheumatism. 2008; 58: 657-666

    • Brown LM
    • Gridley G.
    • Check D.
    • Rundgren O.

    Risk of Multiple Myeloma and Monoclonal Immunoglobulinemia of Undetermined Significance Among White and Black Male U.S. Veterans With Histories of Autoimmune, Infectious, Inflammatory, and Allergic Diseases .

    blood. 2008; 111: 3388-3394

    • Anderson LA
    • Gadala S.
    • Morton LM
    • and others.

    Population-based studies of autoimmune conditions and risk of certain lymphoid malignancies.

    Int J Cancer. 2009; 125: 398-405

    • Anderson LA
    • Pfeiffer RM
    • Rundgren O.
    • Gadala S.
    • Bernd SI
    • Engels EA

    Risk of myeloid malignancies in patients with autoimmune conditions.

    Br J Cancer. 2009; 100: 822-828

    • Lindqvist EK
    • goldin LR
    • Rundgren O.
    • and others.

    A personal and family history of immune-related disease increases the risk of plasma cell disorders: a population-based study.

    blood. 2011; 118: 6284-6291

    • Haeminki K.
    • Ryu X.
    • Felsty A.
    • The J.
    • Sunquist J.
    • Sunquist K.

    Impact of autoimmune disease on subsequent multiple myeloma incidence and survival.

    J Hematol Oncol. 2012; Five: 59

    • Haeminki K.
    • Ryu X.
    • Felsty A.
    • The J.
    • Sunquist J.
    • Sunquist K.

    Subsequent leukemia in patients with autoimmune disease.

    Br J Hematol. 2013; 161: 677-687

    • Farrah M.
    • Ryu X.
    • The J.
    • Felsty A.
    • Sunquist K.
    • Haeminki K.

    Autoimmune diseases associated with non-Hodgkin’s lymphoma: a national cohort study.

    Ann Ongol. 2014; twenty five: 2025-2030

    • Hellgren K.
    • Smedby KE
    • Bucklin C.
    • and others.

    Ankylosing spondylitis, psoriatic arthritis, and malignant lymphoma risk: a cohort study based on national prospective data from Sweden.

    Rheumatoid arthritis. 2014; 66: 1282-1290

    • Farrah M.
    • Ryu X.
    • The J.
    • Felsty A.
    • Sunquist K.
    • Haeminki K.

    Hodgkin lymphoma after autoimmune disease by age at diagnosis and histologic subtype.

    Ann Ongol. 2014; twenty five: 1397-1404

    • Hellgren K.
    • dryer l.
    • Arkema EV
    • and others.
    • Dambio Institute

    Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registries.

    An Reum Dis. 2017; 76: 105-111

    • Sun L.-M.
    • Muo C.-H.
    • Liang J.-A.
    • Chan S.-N.
    • Sung F.-C.
    • Kao C.-H.

    Increased cancer risk in patients with ankylosing spondylitis: a national population-based retrospective cohort study.

    Scan J Rheumatism. 2014; 43: 301-306

    • Chang C.-C.
    • Chan C.-W.
    • Nguyen P.-AA
    • and others.

    Ankylosing spondylitis and cancer risk.

    on corlette. 2017; 14: 1315-1322

    • Chang T.-M.
    • Luo S.-F.
    • Yu K.-H.
    • See L.-C.
    • Yellow L.-H.
    • Kuo C.-F.

    Cancer risk in patients with ankylosing spondylitis: a national cohort study from Taiwan.

    Scan J Rheumatism. 2021; 50: 132-138

    • Nam B.
    • Kim H.
    • Zhang Yizhi
    • Cho S.-K.
    • Sung Y.-K.
    • Kim T.-H.

    Malignant risk in Korean male patients with ankylosing spondylitis.

    Rheumatism International. 2019; 39: 1741-1748

    • Bispo JA
    • Pinheiro PS
    • Cobbets EK

    Epidemiology and etiology of leukemia and lymphoma.

    Cold Spring Herb Perspective Med. 2020; Ten: a034819

    • Yang X.
    • Chen H.
    • Mann J.
    • and others.

    Time trends in incidence and survival rates for all leukemia types in the United States from 1975 to 2017.

    J cancer. 2021; 12: 2326-2335

  • Epidemiology of Axial Spondyloarthritis: An Update.

    Curr Opin rheumatism. 2018; 30: 137-143

    • Dubreuil M.
    • Perroquin C.
    • Zhang Y.
    • Choi HK
    • Inman RD
    • Neogi T.

    Validity of ankylosing spondylitis diagnosis in The Health Improvement Network.

    Pharmacoepidemiol Drug Saf. 2016; twenty five: 399-404

    • Brandenburg NA
    • Phillips S.
    • Wells KE
    • and others.

    Validation of an algorithm in multiple myeloma based on administrative data using the SEER tumor registry and medical record review.

    Pharmacoepidemiol Drug Saf. 2019; 28: 256-263

    • Sia Am
    • Curtis LH
    • Hamill BG
    • Dimartino LD
    • Abernethy AP
    • Shulman KA

    The Medicare Modernization Act of 2003 and its association with patient wait times and travel distances for chemotherapy.

    jam. 2008; 300: 189-196

    • Setoguchi S.
    • Solomon DH
    • Glynn RJ
    • Cook EF
    • Levin R.
    • Schneweiss S.

    Concordance of diagnoses and dates of hematological malignancies and solid tumors between Medicare claims and cancer registry data.

    Cancer causes control. 2007; 18: 561-569

  • Howlader N. Noon AM Klapcho M. SEER Cancer Statistical Review, 1975-2017. National Cancer Institute. Posted on the SEER website based on his SEER data submission in November 2019,
    April 15, 2020 ()
  • Accuracy of diagnosis of inflammatory arthritis in the managed hospitalization database.

    Pharmacoepidemiol Drug Saf. 2021; 30: 257-265

    • Chedani H.
    • Dorshe L.
    • Fumery M.
    • and others.

    Cancer in geriatric-onset inflammatory bowel disease: a population-based study.

    J digestive system. 2016; 111: 1428-1436

    • Bernstein CN
    • Blanchard JF
    • Kliewer E.
    • Waida A.

    Cancer risk in patients with inflammatory bowel disease: a population-based study.

    cancer. 2001; 91: 854-862

    • Ye X.
    • Kasaklang N.
    • Mahmoud SM

    Use of nonsteroidal anti-inflammatory drugs and risk of non-Hodgkin’s lymphoma: a systematic review and meta-analysis.

    Hematol Oncol. 2015; 33: 176-186

    • Reebaud M.
    • Larson MC
    • thompson, california
    • and others.

    Aspirin and other nonsteroidal anti-inflammatory drugs, statins, and the risk of non-Hodgkin’s lymphoma.

    Int J Cancer. 2021; 149: 535-545

    • Rainier G.
    • Rainier JC
    • Garden Bath Pan M.
    • Schvaye A.
    • Boisson M.
    • frez d.

    Ankylosing spondylitis and monoclonal immunoglobulinemia.

    An Reum Dis. 1992; 51: 951-954

    • Wendling D.
    • Platy C.
    • Berthelot J.-M.
    • Claude Pierre P.
    • Pham T.

    Spondyloarthritis and monoclonal immunoglobulinemia.

    Articular bone spine. 2012; 79: 327-329

  • Ionizing radiation as a risk factor for lymphoma: a review.

    J Radiol Prot. 2020; 40: R151-R185

    • Zhang J.
    • Xie F.
    • Delzel E.
    • and others.

    Trends in the use of biologics in rheumatoid arthritis patients enrolled in the U.S. Medicare program.

    Arthritis Careless (Hoboken). 2013; 65: 1743-1751

  • You may also like

    Leave a Comment

    Copyright ©️ All rights reserved. | Canadian Trends